Get startedLog in
    Picture of Cynata Therapeutics logo

    CYP — Cynata Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Cynata Signs Licence Agreement With Tekcyte To Advance Clinical Trial In Diabetic Foot Ulcers

    Picture of Cynata Therapeutics logoCynata Therapeutics
    03/06/2021 13:26
    June 3 (Reuters) - Cynata Therapeutics Ltd  CYP.AX :
    * CYNATA SIGNS LICENCE AGREEMENT WITH TEKCYTE TO ADVANCE
CLINICAL
TRIAL IN DIABETIC FOOT ULCERS
    * CYNATA SIGNS LICENCE AGREEMENT WITH TEKCYTE TO ADVANCE
CLINICAL
TRIAL IN DIABETIC FOOT ULCERS
    * CYNATA THERAPEUTICS LTD - CYNATA HAS ALSO SECURED AN
OPTION TO
PURCHASE RELEVANT TECHNOLOGY OUTRIGHT

Source text for Eikon:  ID:nGNX44R6n 
Further company coverage:  CYP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cynata Therapeutics

    See all news